diazepam nasal spray

DRUG3 trials

Sponsors

Acorda Therapeutics

Conditions

EpilepsyHealthyRefractory Epilepsy

Phase 1

A Pharmacokinetic Study to Assess Dose Proportionality, Safety and Tolerability of Diazepam Nasal Spray in Healthy Adult Volunteers

CompletedNCT02663999

Acorda TherapeuticsHealthy

Start: 2016-01-31End: 2016-06-30Updated: 2016-06-13

Phase 2

An Open-Label, Safety and Tolerability Study of Chronic Intermittent Use of Diazepam Nasal Spray.

TerminatedNCT02316847

Acorda TherapeuticsEpilepsy

Start: 2014-12-31End: 2016-09-30Updated: 2018-07-30

Bioavailability, Safety and Tolerability of Diazepam Nasal Spray Versus Diazepam Rectal Gel (Diastat®)

TerminatedNCT02474407

Acorda TherapeuticsRefractory Epilepsy

Start: 2015-06-30End: 2016-07-31Updated: 2018-10-16